Piroxicam-β-cyclodextrin: a GI safer piroxicam

Item

http://www.wikidata.org/entity/Q27023475

description

2013 nî lūn-bûn

@nan

2013 թուականին հրատարակուած գիտական յօդուած

@hyw

2013 թվականին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Piroxicam-β-cyclodextrin: a GI safer piroxicam

@ast

Piroxicam-β-cyclodextrin: a GI safer piroxicam

@en

Piroxicam-β-cyclodextrin: a GI safer piroxicam

@nl

type

Item

label

Piroxicam-β-cyclodextrin: a GI safer piroxicam

@ast

Piroxicam-β-cyclodextrin: a GI safer piroxicam

@en

Piroxicam-β-cyclodextrin: a GI safer piroxicam

@nl

prefLabel

Piroxicam-β-cyclodextrin: a GI safer piroxicam

@ast

Piroxicam-β-cyclodextrin: a GI safer piroxicam

@en

Piroxicam-β-cyclodextrin: a GI safer piroxicam

@nl

P1476

Piroxicam-β-cyclodextrin: a GI safer piroxicam

@en

P2093

Scarpignato C

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 2.5 Unported

P2860

Cardiovascular risk with non-steroidal anti-inflammatory drugs: systematic review of population-based controlled observational studies

Nonsteroidal anti-inflammatory drugs for dysmenorrhoea

Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials

Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis

Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis

Cohort study of hepatotoxicity associated with nimesulide and other non-steroidal anti-inflammatory drugs

Time dependent risk of gastrointestinal complications induced by non-steroidal anti-inflammatory drug use: a consensus statement using a meta-analytic approach

EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT)

Review article: should NSAID/low-dose aspirin takers be tested routinely for H. pylori infection and treated if positive? Implications for primary risk of ulcer and ulcer relapse after initial healing

Gastrointestinal safety of selective COX-2 inhibitors

P304

2415-37

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.2174/09298673113209990115

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235440037

http://www.w3.org/2001/XMLSchema#string

P698

23394552

http://www.w3.org/2001/XMLSchema#string

P921

Angliavandeniai

heterocyclic compound

polycyclic compound

Amathumbu

P932

3664509

http://www.w3.org/2001/XMLSchema#string